NORTH AMERICA AND EUROPE DERMAL FILLER MARKET ANALYSIS

Market News

North America and Europe Dermal Fillers Market: Key Trends

Approval of newer products and technological advancements can drive the growth of market

Due to improved healthcare infrastructure, effective government policies, a sizable base of multinational corporations, the Dermal Fillers Market is expected to experience considerable expansion in the North American and Europe region.

For instance, in February 15, 2023, Neauvia organic fillers manufactured by Matex Lab Spa, a Italy-based company, scored CE marking under the European Union’s new Medical Device Regulation (MDR) for its range of facial dermal fillers products.

In October 2021, U.S. Food and Drug Administration approved , product of Prollenium, a Canada-based medical technology company. It is a new HA dermal filler product was officially launched onto the U.K. market. It reduces irritation, pain and swelling due to their smaller surface area, when used in minimum volume. The filler also undergoes a purification process to remove impurities after being wet milled and sieved to produce a uniformly cross-linked gel that is designed to degrade at an even rate.

North America and Europe Dermal Fillers Market : Key Developments

Major players in the market are focused on adopting collaboration and partnership strategies to expand their product portfolio.

For instance, in January 2020, Revance Therapeutics, Inc. a U.S. based aesthetics company signed an agreement with TEOXANE SA, a U.K.-based COSMECEUTICAL company for distribution of TEOXANE SA’s Resilient Hyaluronic Acid technology in the U.S.

In January 2020, Histogen, Inc., a U.S.-based  company, expanded its partnership with Allergan, Inc. U.S.-based pharmaceutical company, under which Allergan acquired exclusive rights to incorporate and commercialize Histogen's cell conditioned media in microdermabrasion therapies and exclusive rights to new Histogen intellectual property in the aesthetic field.